Asian Journal of Research in Pharmaceutical Science

Alzheimer s disease (AD) is characterized by an menacing loss of recollection, connected purposeful refuse, and behavioral disorder. Patients may liver for more than a decade after they are diagnosed with AD, making it the important cause of disability in the aged. The treatments of alternative in AD are cholinesterase inhibitors and NMDA-receptor Antagonists. As cholinergic purpose is requisite for short-term memory, the cholinergic shortage in AD was also supposed to be accountable for much of the short-term memory shortage. Herbal medicine products have been used in the handling of Behavioral and Psychological Symptoms of Dementia (BPSD) but with different responses. Although some Food and Drug Administration-approved drugs are accessible for the treatment of AD, the outcomes are often insufficient, and there is a place for herbal medicine. The prearranged assessment recognized two herbs and herbal formulations for the treatment of AD: Melissa officinalis, Salvia officinalis and Yi-Gan San and BDW (Ba Wei Di Huang Wan). Ginkgo biloba All five herbs are useful for cognitive injury of AD. These herbs and formulations have confirmed good therapeutic usefulness but these results need to be compare with those of conventional drugs.